• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: BOSTON SCIENTIFIC CORPORATION SYNERGY XD; CORONARY DRUG-ELUTING STENT

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

BOSTON SCIENTIFIC CORPORATION SYNERGY XD; CORONARY DRUG-ELUTING STENT Back to Search Results
Lot Number 0029012509
Device Problem Entrapment of Device (1212)
Patient Problem No Clinical Signs, Symptoms or Conditions (4582)
Event Date 08/19/2022
Event Type  malfunction  
Event Description
It was reported the stent was entrapped on the guidewire.A percutaneous coronary intervention (pci) was performed on a distal right coronary artery (rca).A 2.25 x 24 mm synergy xd stent was advanced to the target lesion, but resistance occurred.It was not possible to advance the stent through the lesion.An attempt to remove the stent was made, but resistance occurred.The stent device had locked onto the guidewire.The device was removed and the procedure was completed with a non boston scientific device.No patient complications resulted in relation to this event, and the patient was reported to be fine.
 
Event Description
It was reported the stent was entrapped on the guidewire.A percutaneous coronary intervention (pci) was performed on a distal right coronary artery (rca).A 2.25 x 24 mm synergy xd stent was advanced to the target lesion, but resistance occurred.It was not possible to advance the stent through the lesion.An attempt to remove the stent was made, but resistance occurred.The stent device had locked onto the guidewire.The device was removed and the procedure was completed with a non boston scientific device.No patient complications resulted in relation to this event, and the patient was reported to be fine.It was further reported that the less than 50% stenosed target lesion was located in the calcified but excentric right coronary artery (rca) 2, after genius superius.The lesion was prepared with a (nc) balloon and intravascular ultrasound (ivus) confirmed the excentric calcification.No further patient complications were reported in relation to this event.
 
Manufacturer Narrative
Additional information: added to b5.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
SYNERGY XD
Type of Device
CORONARY DRUG-ELUTING STENT
Manufacturer (Section D)
BOSTON SCIENTIFIC CORPORATION
two scimed place
maple grove MN 55311
Manufacturer (Section G)
BOSTON SCIENTIFIC CORPORATION
ballybrit business park
galway
EI  
Manufacturer Contact
jay johnson
4100 hamline ave n
arden hills, MN 55112
6515810888
MDR Report Key15402402
MDR Text Key299695938
Report Number2124215-2022-35352
Device Sequence Number1
Product Code NIQ
Combination Product (y/n)Y
Reporter Country CodeFR
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type Foreign,Health Professional,Company Representative
Reporter Occupation Physician
Type of Report Initial,Followup
Report Date 09/28/2022
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? No
Is this a Product Problem Report? Yes
Device Operator Health Professional
Device Expiration Date02/29/2024
Device Lot Number0029012509
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Initial Date Manufacturer Received 08/19/2022
Initial Date FDA Received09/12/2022
Supplement Dates Manufacturer Received09/07/2022
Supplement Dates FDA Received09/29/2022
Was Device Evaluated by Manufacturer? Device Not Returned to Manufacturer
Date Device Manufactured03/01/2022
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
-
-